PMID: 6539430Jun 1, 1984Paper

High-dose monotherapy in treatment of intractable seizures

Neurology
R P LesserD S Dinner

Abstract

We evaluated the therapeutic efficacy and toxicity of high-dose monotherapy, using carbamazepine or phenytoin, in patients with previously uncontrolled seizures. Treatment with a single drug was equal to or better than polypharmacy, but only a few patients became free of seizures. Toxicity was mild and associated with higher total plasma levels after polypharmacy. Free fractions ranged from 0.14 to 0.30 for carbamazepine and from 0.60 to 0.13 for phenytoin. Toxicity was associated with free phenytoin levels above 3 micrograms/ml; there was no clear relationship between free carbamazepine level and toxicity.

Citations

Jan 1, 1986·European Journal of Clinical Pharmacology·G J MacpheeM J Brodie
Jan 1, 1992·Pharmacology & Therapeutics·W H Theodore
Sep 9, 1989·Lancet
Aug 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A DelckerH C Diener
Oct 1, 1997·Journal of Clinical Pharmacy and Therapeutics·C L DeckersW O Renier
Jan 1, 1987·Epilepsia·W E Dodson
Jan 1, 1987·Epilepsia·W E Dodson
Jan 1, 1987·Epilepsia·E H Reynolds
Jan 1, 1988·Epilepsia·B F Bourgeois
Jan 1, 1993·Epilepsia·S C Schachter
Sep 1, 1985·Postgraduate Medical Journal·G J Macphee, M J Brodie
Dec 13, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Amitava Dasgupta
Apr 1, 1995·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N Y LorenzoW H Theodore
Jan 1, 1989·European Journal of Clinical Pharmacology·G TedeschiV Bonavita
May 22, 2002·Therapeutic Drug Monitoring·Eran KozerGideon Koren
Dec 1, 1990·Mayo Clinic Proceedings·G D Cascino
Mar 1, 1989·British Journal of Clinical Pharmacology·J G LarkinM J Brodie
Oct 10, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Amitava Dasgupta
Nov 22, 1990·The New England Journal of Medicine·M L Scheuer, T A Pedley
Apr 1, 1988·Clinical EEG (electroencephalography)·A FoisF DeFeo
Oct 5, 2017·CNS Drugs·Bassel Abou-Khalil
Aug 1, 1991·Scottish Medical Journal·J M Gray, C Espie
Jan 1, 1986·European Journal of Clinical Pharmacology·G J MacPheeM J Brodie
Mar 1, 1985·Postgraduate Medicine·R P Lesser, C E Pippenger
Aug 1, 1988·Developmental Medicine and Child Neurology·J Aicardi
Oct 1, 1993·The Annals of Pharmacotherapy·M D Privitera
Jul 1, 1985·Clinical EEG (electroencephalography)·R J BurgessG W Paulson
Oct 1, 1991·Italian Journal of Neurological Sciences·L ParisG Sideri
Feb 22, 2021·Journal of Pharmaceutical Sciences·Mauricio A GarcíaPeter Langguth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.